MedPath

MiDura-Study (Neuro-Patch in Duraplasty)

Active, not recruiting
Conditions
Duraplasty
Tumor, Brain
Hydrocephalus
Dural Fistula
Vascular Malformation
Meningioma
Chiari Malformation
Tethered Cord
Craniotomy
Spinal Surgery
Registration Number
NCT04189172
Lead Sponsor
Aesculap AG
Brief Summary

The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
328
Inclusion Criteria
  • Written informed consent
  • Age > 18 years
  • Duraplasty using Neuro-Patch® according to the Instructions for Use
Exclusion Criteria
  • Use in infected regions
  • Use in open cerebrocranial traumata
  • Use in open spina bifida
  • Known hypersensitivity to implant materials
  • Pregnancy
  • Representation by a legal guardian or under involuntary commitment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of complicationsuntil follow-up (up to one year after surgery)

Incidence of complications, with (potential) causal relationship to Neuro-Patch

Secondary Outcome Measures
NameTimeMethod
Handling measuresIntraoperative

Evaluation of handling characteristics using a questionnaire containing 5-level Likert scales (excellent, very good, good, fair, poor)

Incidence of complications not related to Neuro Patchuntil follow-up (up to one year after surgery)

Incidence of complications, without causal relationship to Neuro-Patch

Trial Locations

Locations (4)

Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes

🇩🇪

Homburg/Saar, Germany

Hopital Pierre Wertheimer - HCL

🇫🇷

Bron, France

Service de Neurochirurgie, Hôpital de la Cavale Blanche

🇫🇷

Brest, France

Krankenhaus Ludmillenstift

🇩🇪

Meppen, Germany

© Copyright 2025. All Rights Reserved by MedPath